Onconic Therapeutics Inc. (KOSDAQ:476060)
15,770
-80 (-0.50%)
Jun 10, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 716.08 billion as of June 10, 2026. Its market cap has increased by 192.52% in one year.
Market Cap
716.08B
Enterprise Value
658.89B
Revenue
67.20B
Ranking
n/a
PE Ratio
35.23
Stock Price
15,770.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 716.08B, an increase of 283.12%. That is a compound annual growth rate of 148.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 716.08B | -17.67% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 1.34T |
| Chabiotech | 1.07T |
| Pharmicell | 787.08B |
| GI Innovation | 745.44B |
| Medy-Tox | 518.51B |
| GC Corp. | 448.12B |
| MEDIPOST | 384.99B |
| Proteina | 384.58B |